Ironwood Pharmaceuticals | Gastos De Venta Y Administración



Selling And Administration Expenses Cambio Fecha
Acadia Pharmaceuticals USD 130.08M 3.21M 2024-12
Agios Pharmaceuticals USD 41.53M 10.17M 2025-03
Almirall EUR -50222000 162.22M 2024-06
Alnylam Pharmaceuticals USD 239.95M 55.39M 2025-03
Amarin USD 36.9M 1.64M 2024-09
Ardelyx USD 76.07M 11.1M 2024-12
Astellas Pharma JPY 211.32B 13.99B 2025-03
AstraZeneca USD 3.59B 1.96B 2025-03
Charles River Laboratories USD 188.26M 946K 2024-12
Exact Sciences USD 485M 114.56M 2025-03
Halozyme Therapeutics USD 42.25M 1.01M 2024-12
Incyte USD 325.69M 1.02M 2025-03
Ironwood Pharmaceuticals USD 33.33M 2.78M 2024-12
MacroGenics USD 27.81M 13.71M 2024-12
Moderna USD 212M 139M 2025-03
Myriad Genetics USD 136M 3.1M 2024-12
Pacira USD 79.61M 5.28M 2024-12
PTC Therapeutics USD 84.68M 11.23M 2024-12
Sarepta Therapeutics USD 163.87M 35.67M 2024-12
Takeda JPY 270.59B 2.31B 2024-12
Ultragenyx Pharmaceutical USD 82.49M 2.14M 2024-12



Ironwood Pharmaceuticals Gastos De Venta Y Administración - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.